AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Retrieved on: 2025-04-25 21:14:37

Tags for this article:

Click the tags to see associated articles and topics

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance. View article details on hiswai:

Excerpt

IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical ...

Article found on: www.tradingview.com